<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345685</id>
  <title nil="true"/>
  <common-name>1-chloro-3-[4-[10-[4-(3-chloro-2-hydroxypropyl)-1-methylpiperazin-1-ium-1-yl]decyl]-4-methylpiperazin-4-ium-1-yl]propan-2-ol</common-name>
  <description>1-chloro-3-[4-[10-[4-(3-chloro-2-hydroxypropyl)-1-methylpiperazin-1-ium-1-yl]decyl]-4-methylpiperazin-4-ium-1-yl]propan-2-ol has the chemical formula C26H54Cl2N4O2+2. With an average molecular weight of 525.60 g/mol, 1-chloro-3-[4-[10-[4-(3-chloro-2-hydroxypropyl)-1-methylpiperazin-1-ium-1-yl]decyl]-4-methylpiperazin-4-ium-1-yl]propan-2-ol is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>12252611</pubchem-id>
  <chemical-formula>C26H54Cl2N4O2+2</chemical-formula>
  <weight>525.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:37:32Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:37:32Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C[N+]1(CCN(CC1)CC(CCl)O)CCCCCCCCCC[N+]2(CCN(CC2)CC(CCl)O)C</moldb-smiles>
  <moldb-formula>C26H54Cl2N4O2+2</moldb-formula>
  <moldb-inchi>InChI=1S/C26H54Cl2N4O2/c1-31(17-11-29(12-18-31)23-25(33)21-27)15-9-7-5-3-4-6-8-10-16-32(2)19-13-30(14-20-32)24-26(34)22-28/h25-26,33-34H,3-24H2,1-2H3/q+2</moldb-inchi>
  <moldb-inchikey>JGGYHOORWZURGZ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">524.3623824</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341578</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>1-chloro-3-[4-[10-[4-(3-chloro-2-hydroxypropyl)-1-methylpiperazin-1-ium-1-yl]decyl]-4-methylpiperazin-4-ium-1-yl]propan-2-ol</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296041</sync-id>
  <structure-inchikey>JGGYHOORWZURGZ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000000000800000000000000000000000000000000000100000000000000000000000000000000000000000000000002000009000080000000000000000000000000000000000000000000000000000000000000000000000020000000000010000000000000000000000000000021100000000000000000000000000004040000000000004008000010000000000800000000000000000000000000000000000000000000000000000000000000000000000008040000000040000000000000000010000001000000000000010000000000000004000000000010000000000000000000000000000010020000000040000000000000000000200</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAIwAAAIABBgBgAAAAAQMHICIAAAAB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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:39Z</structure-indexed-at>
</compound>
